Echelon gets U.S. grant for microarrays

Nov. 6, 2002 — Echelon Biosciences Inc. said it has received $200,000 from the National Institutes of Health to develop microarrays used in the fight against cancer.

null

The two-year grant provides Echelon with funds to develop Lipid Chip microarrays, which will be used as a screening tool to discover compounds to identify and selectively eliminate cancer cells. The company said its approach should permit early detection of errors in cellular communication that can be treated and cured, according to a news release.

null

The Salt Lake City company was founded in 1997 by University of Utah scientists.

null

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.